Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
26%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
30%
ALSO IN AGNG
AGNG
83
HOLDINGS
10%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus AGNG)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 21.2% | 4.1% | 4.1% |
|
ABBVIE INC | 10.1% | 3.8% | 3.8% |
|
AMGEN INC | 4.9% | 3.6% | 3.6% |
|
MERCK & CO. INC. | 4.5% | 3.4% | 3.4% |
|
JOHNSON & JOHNSON | 5.8% | 3.1% | 3.1% |
MEDX Overweight Relative to AGNG
|
ELI LILLY & CO | 17.1% |
 |
NOVARTIS AG-ADR | 6.9% |
|
ABBVIE INC | 6.3% |
 |
ALKERMES PLC | 4.6% |
|
BIOGEN IDEC INC | 3.5% |
|
PFIZER INC | 3.5% |
|
JOHNSON & JOHNSON | 2.7% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 2.5% |
|
CRISPR THERAPEUTICS AG | 2.4% |
|
IONIS PHARMACEUTICALS, INC. | 2.4% |
MEDX Underweight Relative to AGNG
|
ROCHE HOLDING AG-BR | -3.3% |
|
EDWARDS LIFESCIENCES CORP | -3.2% |
|
WELLTOWER, INC. | -3.1% |
|
MEDTRONIC PLC | -3.0% |
 |
NOVO NORDISK A/S-B | -2.9% |
|
SANDOZ GROUP AG | -2.8% |
|
VENTAS INC | -2.7% |
 |
UCB SA | -2.7% |
|
BEIGENE LTD. SPONSORED ADR | -2.6% |
|
GENMAB A/S | -2.4% |